30.06.2020 IBU-tec advanced materials AG  DE000A0XYHT5

DGAP-News: IBU-tec advanced materials AG: IBU-tec supplies internationally active Asian pharmaceutical group


 

DGAP-News: IBU-tec advanced materials AG / Key word(s): Miscellaneous
IBU-tec advanced materials AG: IBU-tec supplies internationally active Asian pharmaceutical group

30.06.2020 / 10:00
The issuer is solely responsible for the content of this announcement.


IBU-tec supplies internationally active Asian pharmaceutical group

- Another pharmaceutical company places an order with IBU-tec for a drug to lower blood pressure

- IBU-tec sees further potential for distribution of the organotin catalyst

- More than 1.1 billion people worldwide suffer from high blood pressure


Weimar, 30 June 2020 - IBU-tec advanced materials AG ("IBU-tec", ISIN: DE000A0XYHT5) reports another successful sales performance in the pharmaceutical sector. For the first time, IBU-tec is supplying an internationally active pharmaceutical group from Asia with a chemical catalyst, to produce a generic drug to lower blood pressure. The first delivery in the double-digit ton range has already been completed and invoiced. Just recently, a further global pharmaceutical group extended an agreement for the purchase of this catalyst from IBU-tec unexpectedly. The organotin compound is a product of the IBU-tec subsidiary BNT Chemicals.

IBU-tec sees further sales and turnover potential for the distribution of the organotin catalyst in the coming years. In recent decades, the number of people suffering from high blood pressure has risen continuously. There are now more than 1.1 billion people suffering from hypertension worldwide, an increasing proportion of whom live in developing and emerging countries.

Ulrich Weitz, CEO of IBU-tec: "Our recent achievements in the pharmaceutical industry fill us with optimism. They also underpin the broad diversification of IBU-tec. After all, battery materials and air purification solutions, for example, are also areas in which we are strong. With our own products for the pharmaceutical industry, we are now tapping into further potential".

About IBU-tec

The IBU-tec Group develops and produces innovative materials of the highest quality for the industry. It combines unique, partly patent-protected thermal process engineering, with the process and material know-how of around 250 highly qualified employees.

The products are important components of battery materials for electric mobility and stationary energy storage, as well as solutions for air purification, resource conservation or the reduction of plastic packaging. IBU-tec is thus in a long-term position to respond to global megatrends, especially in the fields of climate and environmental protection. It has an international customer base ranging from innovative medium-sized companies to global corporations.

Further information can be found online at www.ibu-tec.de.
 

Contact

edicto GmbH
Axel Mühlhaus
Eschersheimer Landstraße 42-44
60322 Frankfurt
Tel. +49 (0) 69-905505-52
E-Mail: [email protected]

IBU-tec advanced materials AG
Max Narr
Hainweg 9-11
99425 Weimar
Tel.+49 (0) 151 67955683
E-Mail: [email protected]



30.06.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: IBU-tec advanced materials AG
Hainweg 9-10
99425 Weimar
Germany
Phone: +49 (0)3643 - 8649-0
Fax: +49 (0)3643 - 8649-30
E-mail: [email protected]
Internet: www.ibu-tec.de
ISIN: DE000A0XYHT5
WKN: A0XYHT
Indices: Scale 30
Listed: Regulated Unofficial Market in Frankfurt (Scale), Tradegate Exchange
EQS News ID: 1082033

 
End of News DGAP News Service

1082033  30.06.2020 

fncls.ssp?fn=show_t_gif&application_id=1082033&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2016 2017 2018 2019 2020 2021 2022e
Umsatzerlöse1 17,74 16,81 46,57 48,45 32,96 44,09 56,00
EBITDA1,2 6,20 2,66 6,91 7,12 6,98 5,53 7,40
EBITDA-Marge3 34,95 15,82 14,84 14,70 21,18 12,54 13,21
EBIT1,4 4,14 0,30 2,55 1,95 2,08 0,94 2,30
EBIT-Marge5 23,34 1,78 5,48 4,03 6,31 2,13 4,11
Jahresüberschuss1 2,85 0,17 2,33 0,87 1,00 -0,24 1,10
Netto-Marge6 16,07 1,01 5,00 1,80 3,03 -0,54 1,96
Cashflow1,7 3,77 0,78 3,31 4,23 4,47 -1,13 3,90
Ergebnis je Aktie8 0,71 0,04 0,35 0,22 0,25 -0,05 0,23
Dividende8 0,13 0,13 0,20 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2021 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: KPMG

INVESTOR-INFORMATIONEN
©boersengefluester.de
IBU-tec advanced materials
WKN Kurs in € Einschätzung Börsenwert in Mio. €
A0XYHT 35,500 Kaufen 168,63
KGV 2024e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
20,88 42,76 0,49 101,72
KBV KCV KUV EV/EBITDA
2,90 - 3,82 28,72
Dividende '22 in € Dividende '23e in € Div.-Rendite '22e
in %
Hauptversammlung
0,00 0,00 0,00 26.04.2023
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
31.08.2022 26.04.2023
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
11,61% 30,85% 3,50% -7,31%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu IBU-tec advanced materials AG  ISIN: DE000A0XYHT5 können Sie bei EQS abrufen


Chemie , A0XYHT , IBU , XETR:IBU